Nordic RBC Group

Clinical Trials

  • SATISFY
    Patient group: RBC membranopathies (spherocytosis, stomatocytosis), congenital dyserythropoietic anemia type II
  • P-SP420-THAL-01
    Patient group: Transfusion dependent beta-thalassemia